It was reported that this patient experienced symptoms of chest pain and dizziness and received anti-tachycardia pacing (atp) therapy and 8 total shocks from their cardiac resynchronization therapy defibrillator (crt-d) device.The shocks were noted to have successfully converted the patients atrial fibrillation (af) rhythm but the shocks failed to convert the patients ventricular tachycardia (vt) rhythm and therapy was exhausted, but the vt rhythm converted on its own.Subsequent defibrillation threshold (dft) testing was performed with the crt-d device programmed such that the upper right ventricular (rv) lead shocking coil was deactivated, leaving the other lower rv lead shocking coil active and programmed in a lead to device can configuration.During this dft testing, successful conversion was achieved with a shock of 31 joules.In addition, the patient was started on medication.The device remains in-service.No additional adverse patient effects were reported.
|